Matthew E. Monaghan
CIK 1638490 · Chairman, President and CEO · last filed 2023-09-28
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
IVC price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
ELYRIA, OH 44035
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Syneos Health, Inc. (SYNH) Delisted | Director | 4,863 | $42.98 | $209.0K | -$29.9K | 9 | 2023-09-28 |
| INVACARE HOLDINGS Corp (IVC) Delisted | Chairman, President and CEO | 1,299,292 | $0.66 | $857.3K | $397.8K | 24 | 2022-05-17 |
| INCR | Director | 783 | $4.53 | $3.5K | $0 | 2 | 2017-05-24 |
Recent Filings · Page 2 of 4
35 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-04-07 | INVACARE HOLDINGS Corp (IVC) Delisted | Mixed | +82,857 | -$566.3K | EDGAR |
| 2021-03-16 | INVACARE HOLDINGS Corp (IVC) Delisted | Grant (A) | +130,840 | $0 | EDGAR |
| 2020-05-29 | Syneos Health, Inc. (SYNH) Delisted | Grant (A) | +2,803 | $175.0K | EDGAR |
| 2020-05-19 | INVACARE HOLDINGS Corp (IVC) Delisted | Tax (F) | −41,326 | -$233.9K | EDGAR |
| 2020-04-23 | INVACARE HOLDINGS Corp (IVC) Delisted | Tax (F) | −116,381 | -$1.01M | EDGAR |
| 2020-03-31 | INVACARE HOLDINGS Corp (IVC) Delisted | Grant (A) | +265,557 | $0 | EDGAR |
| 2020-02-21 | INVACARE HOLDINGS Corp (IVC) Delisted | Mixed | +219,358 | -$667.2K | EDGAR |
| 2019-05-29 | Syneos Health, Inc. (SYNH) Delisted | Grant (A) | +4,122 | $175.0K | EDGAR |
| 2019-05-17 | INVACARE HOLDINGS Corp (IVC) Delisted | Tax (F) | −26,377 | -$179.4K | EDGAR |
| 2019-03-19 | INVACARE HOLDINGS Corp (IVC) Delisted | Grant (A) | +144,361 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.